Split crest technique for implant treatment of agenesis of the upper lateral incisors: results of a randomized pilot histological and clinical study at 24-month follow-up.


Journal

Brazilian oral research
ISSN: 1807-3107
Titre abrégé: Braz Oral Res
Pays: Brazil
ID NLM: 101307187

Informations de publication

Date de publication:
04 Sep 2020
Historique:
received: 08 03 2020
accepted: 10 07 2020
entrez: 9 9 2020
pubmed: 10 9 2020
medline: 21 10 2020
Statut: epublish

Résumé

Agenesis of lateral incisors, besides the functional issues, represents a great esthetic drawback. The selection of an appropriate treatment is a complex decision, which should consider the stability of the clinical outcomes over time. The aim of the present study was a histological and clinical comparison of two-stage split crest technique (SCT), with bone chips alone or mixed with porcine bone in patients affected by unilateral and bilateral agenesis of the upper lateral incisors. Eleven patients were enrolled, and randomly assigned to receive a treatment with autologous bone chips (group 1) or autologous bone chips mixed 1:1 to porcine-derived xenogenic bone (group 2). After a 2-month healing period, implants were placed and biopsies harvested for histomorphometrical evaluation. Clinical assessment, according to ICOI PISA health scale, and radiographic marginal bone loss evaluation at 12- and 24-month follow-ups were conducted. The histomorphometry showed significantly greater new bone formation (p > 0.0229) in group 2. At 12- and 24-month follow-ups, all the evaluated implants, regardless of the group they were allocated, could be categorized as "success" in the ICOI Pisa Health Scale for Dental Implants, and did not show significant difference in crestal bone loss. To the best of our knowledge, these are the first histological and clinical outcomes indicating that the use of bone chips mixed 1:1 to porcine bone in SCT could be a promising technique for the rehabilitation of patients with agenesis of the upper lateral incisors, although studies with a larger number of patients and implants, and a longer follow up are needed.

Identifiants

pubmed: 32901733
pii: S1806-83242020000100289
doi: 10.1590/1807-3107bor-2020.vol34.0118
pii:
doi:

Substances chimiques

Dental Implants 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e118

Auteurs

Giovanna Iezzi (G)

University of Chieti-Pescara Department of Medical, Oral and Biotechnological Sciences, Chieti, Italy.

Vittoria Perrotti (V)

University of Chieti-Pescara Department of Medical, Oral and Biotechnological Sciences, Chieti, Italy.

Adriano Piattelli (A)

University of Chieti-Pescara Department of Medical, Oral and Biotechnological Sciences, Chieti, Italy.

Camillo D'Arcangelo (C)

University of Chieti-Pescara Department of Medical, Oral and Biotechnological Sciences, Chieti, Italy.

Federica Altieri (F)

Sapienza University of Rome, Department of Oral and Maxillofacial Sciences, Rome, Italy.

Michele Cassetta (M)

Sapienza University of Rome, Department of Oral and Maxillofacial Sciences, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH